U-HO1, A New Cell Line Derived From A Primary Refractory ... - PubMed

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

The Hodgkin cell line U-HO1 was established from a malignant pleural effusion of a 23-year-old male patient during the end stage of refractory nodular sclerosing classical Hodgkin lymphoma (cHL). Since its establishment in 2005, U-HO1 has maintained stable characteristics in vitro and has a doubling time of about 4 days under standard culture conditions. U-HO1 forms typical Reed-Sternberg cells in suspension, is EBV negative, lacks HLA-A, -B, -C but expresses HLA-D proteins/CD74 and exposes CD15 together with CD30 in the absence of CD19 and CD20 on the cell surface. Karyotype analysis of U-HO1 revealed a hyperdiploid karyotype with multiple clonal aberrations. Most significant is an elongated chromosome 2, der(2)t(2;10)(q35; q16.1)add(2)(p13). CGH analysis revealed the following imbalances: ish cgh dim(1)(p13p31)(p12q21), enh(2)(p13p23), dim(4)(q31.3qter), enh(6)(q22q27), enh(12), enh(18), enh(20) (q13.1pter). FISH analysis showed about six-fold amplification of REL and BCL11A, thus, U-HO1 is prototypical for cHL in every aspect tested so far. As an outstanding feature compared to the existing HL cell lines, U-HO1 has high levels of microRNA transcripts of MIRN216 and MIRN217 located in the amplicon 2p16. Compared to other HL cell lines, U-HO1 proved far less genetically aberrant suggesting that U-HO1's imbalances suffice to cause the full-blown phenotype of primary refractory cHL.

Copyright (c) 2008 S. Karger AG, Basel.

PubMed Disclaimer

MeSH terms

• Adult Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cell Line Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chromosome Banding Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Chromosomes, Human, Pair 2 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Gene Expression Regulation, Neoplastic Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Gene Rearrangement, B-Lymphocyte, Heavy Chain Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Hodgkin Disease / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Hodgkin Disease / pathology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Immunophenotyping Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• In Situ Hybridization, Fluorescence Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Karyotyping Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Male Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Polymerase Chain Reaction Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• RNA Precursors / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• RNA Precursors Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • S. Karger AG, Basel, Switzerland

• Medical

  • MedlinePlus Health Information

• Research Materials

  • Cellosaurus - a cell line knowledge resource
  • NCI CPTC Antibody Characterization Program